UNION CITY, Calif.,
March 11, 2014 /PRNewswire/
-- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company
manufacturing point-of-care blood analysis systems, announced today
that Clint Severson, chairman and
chief executive officer , will present at the Sidoti & Company
Eighteenth Annual Institutional Investor Forum on Tuesday, March 18, 2014 at 10:00 a.m. ET. The conference will be held at the
Grand Hyatt New York in New York
City.
About Abaxis
Abaxis develops, manufactures, markets
and sells portable blood analysis systems for use in any veterinary
or human patient-care setting to provide clinicians with rapid
blood constituent measurements. The system consists of a
compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series
of single-use plastic discs, called reagent discs that contain all
the chemicals required to perform a panel of up to 13 tests on
veterinary patients and 14 tests on human patients. The
system can be operated with minimal training and performs multiple
routine tests on whole blood, serum or plasma samples. The
system provides test results in less than 12 minutes with the
precision and accuracy equivalent to a clinical laboratory
analyzer. The veterinary business also provides to the animal
health and research market a line of hematology instruments for
point-of-care complete blood counts (CBC), a specialty instrument
to screen for and detect clotting disorders and to measure equine
fibrinogen levels, a handheld instrument for the rapid assessment
of certain critical care tests and rapid point-of-care tests for
Heartworm infections, Parvovirus, Giardia and Lyme disease.
Abaxis, through its AVRL division, provides routine laboratory
testing as well as specialty testing for veterinarians
nationwide. For more information, visit
http://www.abaxis.com.
Contact:
|
Clint
Severson
|
Lytham Partners,
LLC
|
|
Chief Executive
Officer
|
Joe Dorame, Joe Diaz
& Robert Blum
|
|
ABAXIS,
Inc.
|
602-889-9700
|
|
510-675-6500
|
|
SOURCE Abaxis, Inc.